Market Overview
The South American nuclear imaging market comprises diagnostic imaging equipment and related radiopharmaceuticals used primarily for oncology, cardiology, and neurology applications. The market is valued at approximately $395 million USD in 2025, with projections indicating steady expansion as healthcare systems modernize. Key modalities include PET/CT scanners, SPECT systems, and the associated radiopharmaceutical supply chains required to operate these technologies.
- •Market valued at approximately $395 million in 2025
- •Includes PET/CT, SPECT systems, and radiopharmaceuticals
- •Serves oncology, cardiology, and neurology diagnostic needs
Growth Drivers
The market growth is primarily fueled by the rising incidence of cancer and cardiovascular diseases across South America, which has increased demand for advanced diagnostic imaging. Expanding healthcare infrastructure, government health initiatives, and growing medical tourism in countries like Brazil and Argentina are also contributing factors. Additionally, technological advancements in imaging resolution and reduced radiation doses have made nuclear imaging more accessible to regional hospitals and diagnostic centers.
- •Rising cancer and cardiovascular disease prevalence
- •Healthcare infrastructure expansion in Brazil, Argentina, and other nations
- •Technological improvements reducing radiation and operational costs
Segmentation and Regional Analysis
Brazil represents the largest market share in South America, accounting for a substantial portion of regional revenue due to its developed healthcare system and large patient population. Argentina follows as the second-largest market, with Chile, Colombia, and Peru showing emerging potential as their healthcare investments increase. PET/CT scanners dominate the equipment segment, though SPECT systems maintain relevance due to lower operational costs in price-sensitive markets.
- •Brazil leads as the dominant regional market
- •Argentina and emerging markets like Chile and Colombia show growth potential
- •PET/CT and SPECT are the primary modality segments
Trends and Outlook
What are the recent trends and outlook?
The market is expected to sustain its growth trajectory through 2030, with increasing adoption of hybrid imaging systems that combine multiple diagnostic modalities. Hybrid PET/MRI systems and the development of new radiopharmaceuticals are anticipated to expand clinical applications and drive further market penetration. Ongoing healthcare digitization, improved reimbursement frameworks, and partnerships between public and private healthcare providers are likely to shape the markets evolution over the coming years.
- •Adoption of hybrid imaging systems such as PET/MRI is increasing
- •New radiopharmaceutical development is expanding clinical applications
- •Healthcare digitization and improved reimbursement frameworks support market expansion
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.